• Therapeutical use of probiotic formulations in clinical practice

    From =?UTF-8?B?4oCi?=@21:1/5 to All on Wed Sep 6 23:21:00 2017
    Clinical Nutrition
    Volume 29, Issue 6, December 2010, Pages 701-725
    Review
    Therapeutical use of probiotic formulations in clinical practice
    Author links open overlay panelT.IannittiaB.Palmierib
    Show more
    https://doi.org/10.1016/j.clnu.2010.05.004
    Get rights and content
    Summary
    Background & Aims

    The spreading of gastrointestinal diseases is growing all over the world. Although for some of them an effective therapeutic approach has been found, palliation rather than cure is very frequent due to a partial knowledge of their aethiology and
    pathogenesis. This review, analyzing the main clinical studies, aims at being a state of the art update of the use of probiotic formulations in daily practice.

    Methods

    In this review we include all the most significant clinical trials involving the use of probiotic formulations for the treatment of several pathologies.

    Results

    Dysbiosis has been observed in irritable bowel syndrome patients. Probiotics may exert a beneficial effect on Crohn’s disease affected patients who have shown gut microbiota antigens and altered wall permeability. Moreover some probiotic formulations
    seem to enhance the therapy for Helycobacter Pylori reducing its pathogenic potential. Intestinal ecology imbalance has been also linked to cancer induction, allergy, skin and urogenital diseases. In addition probiotics administration seems to be
    particularly useful to ease post-operative complications.

    Conclusion

    Further future clinical trials, involving large numbers of patients, will be mandatory to achieve definite evidence of the preventive and curative role of probiotics in medical practice.

    Keywords
    ProbioticMicrobiotaDysbiosisDisease


    http://www.sciencedirect.com/science/article/pii/S0261561410000907

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)